Global Search

Search articles, concepts, and chapters

Invest Ophthalmol Vis SciMarch 202029 citations

Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension.

Cao Kejia, Ishida Tomoka, Fang Yuxin, Shinohara Kosei, Li Xuejiao, Nagaoka Natsuko, Ohno-Matsui Kyoko, Yoshida Takeshi


AI Summary

Intravitreal resveratrol protected retinal ganglion cells in a mouse glaucoma model by reducing oxidative stress and boosting neurotrophic factors, suggesting potential as a glaucoma therapy to delay visual loss.

Abstract

Purpose

To investigate the efficacy of intravitreal administration of resveratrol (RSV) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.

Methods

Experiments were performed using adult C57BL/6JJcl mice. Polystyrene microbeads were injected into the anterior chamber to induce IOP elevation. Retinal flat-mounts and sections were assessed by immunohistochemistry to detect the expression of reactive oxygen species and acetyl-p53 in retinal ganglion cells (RGCs), brain-derived neurotrophic factor (BDNF) in Müller glial cells (MGCs), and the receptor tropomyosin receptor kinase B (TrkB) in RGCs. Light cycler real-time PCR was also used for confirming gene expression of BDNF in primary cultured MGCs exposed to RSV.

Results

Microbeads induced high IOP followed by RGC death and axon loss. Administration of RSV rescued RGCs via decreased reactive oxygen species generation and acetyl-p53 expression in RGCs and upregulated BDNF in MGCs and TrkB expression in RGCs, which exhibited a strong cytoprotective action against cell death through multiple pathways under high IOP.

Conclusions

Our data suggest that administration of RSV may delay the progress of visual dysfunction during glaucoma and may therefore have therapeutic potential.


MeSH Terms

AcetylationAnimalsAntioxidantsBrain-Derived Neurotrophic FactorCell DeathCells, CulturedCytoprotectionDisease Models, AnimalDrug Evaluation, PreclinicalIntraocular PressureIntravitreal InjectionsMaleMice, Inbred C57BLMicrospheresOcular HypertensionReactive Oxygen SpeciesResveratrolRetinal Ganglion CellsSirtuin 1Tumor Suppressor Protein p53

Key Concepts6

In a microbead-induced high intraocular pressure (IOP) murine model for glaucoma, microbeads induced high IOP followed by retinal ganglion cell (RGC) death and axon loss.

MechanismBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh5

Administration of resveratrol (RSV) rescued retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.

TreatmentBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh35

Administration of resveratrol (RSV) decreased reactive oxygen species generation and acetyl-p53 expression in retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.

MechanismBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh5Ch35

Administration of resveratrol (RSV) upregulated brain-derived neurotrophic factor (BDNF) in Müller glial cells (MGCs) and tropomyosin receptor kinase B (TrkB) expression in retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.

MechanismBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh5Ch35

Administration of resveratrol (RSV) may delay the progress of visual dysfunction during glaucoma and may therefore have therapeutic potential, based on data from a microbead-induced high intraocular pressure (IOP) murine model.

PrognosisBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh35

Intravitreal administration of resveratrol (RSV) was investigated for its efficacy in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.

MethodologyBasic ScienceExperimental Animal Studyn=Adult C57BL/6JJcl miceCh35

Is this article assigned to the wrong chapter(s)? Let us know.